Tatva Chintan Pharma Chem Limited — Credit Ratings, 17-06-2025: Credit Rating

Crisil Ratings has downgraded Tatva Chintan Pharma Chem Limited’s long-term rating to BBB+ with a stable outlook from A- with a negative outlook, and the short-term rating to A2 from A2+. This downgrade reflects a moderation in the company’s business risk profile. The total rated bank facilities stand at Rs.245 Cr. The rating revision suggests some pressure on credit metrics which could translate into a marginally higher cost of borrowing and cautious investor sentiment. However, the stable outlook indicates an expectation of steady operational performance and manageable liquidity, maintaining reasonable financial flexibility for the company going forward.